
|Articles|March 6, 2013
Common Medication Errors: Drug #6: Ketorolac
Author(s)PedsConLive Staff
Ketorolac is a good option for relieving pain in patients with sickle cell disease, but there can be a problem with how this agent is prescribed for children.
Advertisement
A 5-year-old boy (20 kg) with sickle cell disease presented with a 2-day history of increasingly severe back pain. A detailed workup showed no signs of infection. The patient’s parents did not want their son to take narcotics for the pain. Thus, the boy was given a prescription for ketorolac -- 10 mg PO every 6 hours x 5 days [0.5 mg/kg dose]).
What’s the problem here?
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Steroid Safety, Growth Concerns, and When to Escalate Pediatric Therapy
2
Renuka Dias, PhD, MBBS, highlights feasibility of type 1 diabetes screening in children
3
Infant botulism outbreak linked to powdered formula under FDA investigation
4
FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors
5





